While the Phase 3 trial of vilobelimab in ulcerative pyoderma gangrenosum (PG) was terminated earlier this year due to ...

ST. PAUL, MN / ACCESS Newswire / December 4, 2025 / Odyssey Transfer and Trust Company (“Odyssey” or the “Company“), a leading North American transfer agent and trust company that is scaling rapidly ...

(RTTNews) - Biotechnology company Q32 Bio, Inc. (QTTB) announced Monday it has sold its Phase 2 complement inhibitor, ADX-097, to Akebia Therapeutics, Inc. (AKBA). ADX-097, the lead product candidate ...

Investing.com -- Q32 Bio Inc (NASDAQ:QTTB) stock surged 94% in premarket trading Monday after the clinical-stage biotechnology company announced the sale of its Phase 2 complement inhibitor, ADX-097, ...

Barely two months after emerging from stealth, Hivekind AI has announced the addition of a PR Agent to its existing suite of Agents. The new PR Agent complements the revenue-generating agents Hivekind ...

RICHMOND, Va. (WRIC) — Richmond City Council has approved two hotels to be built in the Scott’s Addition area. In a press release on Nov. 10 that also included announcements on affordable housing and ...

After a busy offseason, the Golden State Warriors have added several new pieces to their roster as they aim for another championship run. With Jonathan Kuminga’s contract situation finally settled, ...

Undercurrent News now provides data licensing, or API access, to our global seafood trade database, an addition to the existing API service on our global and US wholesale seafood price offerings. Data ...

The Vikings aren't messing around when it comes to fixing a running game that has struggled during the first three years of ...

Gayle King showed off her signature colorful style in New York City on Feb. 18, donning a pair of bold purple Christian Louboutin boots to round out a vibrant wintertime ensemble. Gayle King wearing ...

Despite the failure of an eczema trial in December, Q32 Bio is sticking with bempikibart. But a phase 2-stage complement inhibitor and a number of the biotech’s “valued colleagues” won’t be so lucky.

The alternative complement pathway plays a key role in the pathogenesis of IgA nephropathy. Iptacopan specifically binds to factor B and inhibits the alternative pathway. In this phase 3, double-blind ...